Blockade endogenous anterior hypothalamic atrial natriuretic peptide monoclonal antibody lowers pressure hypertensive rats atrial natriuretic peptide ANP content anterior hypothalamic region NaCl-sensitive hypertensive rats SHR-S Wistar-Kyoto WKY rats ANP neuronal norepinephrine release excitability hypothalamic neurons study hypothesis blockade endogenous ANP anterior hypothalamus local microinjection monoclonal antibody ANP MAb KY-ANP-II blood pressure Purified MAb KY-ANP-II micrograms control mouse IgG nl saline anterior hypothalamic area AHA conscious SHR-S WKY rats control Mab KY-ANP-II microgram posterior hypothalamic area PHA Anterior hypothalamic microinjection MAb KY-ANP-II significant dose-related decreases mean arterial pressure MAP heart rate HR SHR-S WKY rats Control injections equal volumes IgG effect MAP HR Microinjection Mab KY-ANP-II PHA significant alteration MAP HR SHR-S data first demonstration endogenous ANP region brain cardiovascular function mediates BP HR control rat findings endogenous ANP anterior hypothalamus SHR-S central regulation BP model 